BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2025 Earnings Call Transcript February 23, 2026
BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.46, expectations were $0.25.
Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the BioMarin Pharmaceutical Fourth Quarter and Full Year 2025 Conference Call. [Operator Instructions] I would now like to turn the call over to...
